Gas chromatography-mass spectrometric study of 19-oxygenation of the aromatase inhibitor 19-methylandrostenedione with human placental microsomes

Biol Pharm Bull. 2006 Jun;29(6):1242-5. doi: 10.1248/bpb.29.1242.

Abstract

To gain insight into the catalytic function of aromatase, we studied 19-oxygenation of 19-methyl-substituted derivative of the natural substrate androstenedione (AD), compound 1, with human placental aromatase by use of gas chromatography-mass spectrometry (GC-MS). Incubation of the 19-methyl derivative 1 with human placental microsomes in the presence of NADPH under an aerobic condition did not yield a detectable amount of [19S]19-hydroxy product 2 or its [19R]-isomer 3 when the product was analyzed as the bis-methoxime-trimethylsilyl (TMS) derivative by GC-MS; moreover, the production of estrogen was not detected as the bis-TMS derivative of estradiol (detection limit: about 3 ng and 10 pg per injection for the 19-ol and estradiol, respectively). The results reveal that the 19-methyl steroid 1 does not serve as a substrate of aromatase, although it does serve as a powerful inhibitor of the enzyme.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstenedione / analogs & derivatives*
  • Androstenedione / chemical synthesis
  • Androstenedione / chemistry
  • Androstenedione / pharmacology*
  • Aromatase / metabolism*
  • Aromatase Inhibitors / chemical synthesis
  • Aromatase Inhibitors / chemistry
  • Aromatase Inhibitors / pharmacology*
  • Female
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • Microsomes / enzymology*
  • Molecular Structure
  • Oxidation-Reduction
  • Oxygen / metabolism*
  • Placenta / enzymology*
  • Pregnancy
  • Substrate Specificity

Substances

  • 19-methylandrost-4-ene-3,17-dione
  • Aromatase Inhibitors
  • Androstenedione
  • Aromatase
  • Oxygen